Cisen Pharmaceutical Co Ltd Class A 603367
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 16.30
- Day Range
- CNY 16.15–16.47
- 52-Week Range
- CNY 11.34–17.45
- Bid/Ask
- CNY 16.16 / CNY 16.18
- Market Cap
- CNY 7.32 Bil
- Volume/Avg
- 1.9 Mil / 3.5 Mil
Key Statistics
- Price/Earnings (Normalized)
- 15.73
- Price/Sales
- 1.65
- Dividend Yield (Trailing)
- 2.06%
- Dividend Yield (Forward)
- 2.06%
- Total Yield
- 2.06%
Company Profile
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 3,413
- Website
- http://www.lkcisen.com
Comparables
Valuation
|
Metric
|
603367
|
600557
|
603139
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.73 | 21.86 | — |
Price/Book Value | 1.25 | 2.15 | 1.48 |
Price/Sales | 1.65 | 2.32 | 2.12 |
Price/Cash Flow | 12.35 | 8.71 | — |
Price/Earnings
603367
600557
603139
Financial Strength
|
Metric
|
603367
|
600557
|
603139
|
|---|---|---|---|
Quick Ratio | 2.84 | 2.19 | 0.77 |
Current Ratio | 3.62 | 2.52 | 1.28 |
Interest Coverage | 84.52 | — | −3.95 |
Quick Ratio
603367
600557
603139
Profitability
|
Metric
|
603367
|
600557
|
603139
|
|---|---|---|---|
Return on Assets (Normalized) | 6.25% | 7.20% | −3.61% |
Return on Equity (Normalized) | 7.93% | 9.86% | −7.25% |
Return on Invested Capital (Normalized) | 7.24% | 9.16% | −3.32% |
Return on Assets
603367
600557
603139
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Jcqgqbhsds | Xbpvgf | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Ktwvtmzys | Hydq | $79.3 Bil | |
HLN
| Haleon PLC ADR | Glbvpmqdx | Vgzmf | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Fjdyjyl | Zmfd | $18.9 Bil | |
VTRS
| Viatris Inc | Rvsgmpm | Szqss | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hnrgkjdk | Qgyt | $11.7 Bil | |
CTLT
| Catalent Inc | Rzmwtntx | Rtrwn | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Nvqqdjqz | Rbxyl | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Crcqfdgs | Qpd | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fghcllydx | Mkcfkc | $3.2 Bil |